| Legal changes to increase access to naloxone for opioid overdose reversal in the United States CS Davis, D Carr Drug and alcohol dependence 157, 112-120, 2015 | 185 | 2015 |
| State legal innovations to encourage naloxone dispensing C Davis, D Carr Journal of the American Pharmacists Association 57 (2), S180-S184, 2017 | 140 | 2017 |
| Engaging law enforcement in overdose reversal initiatives: authorization and liability for naloxone administration CS Davis, D Carr, JK Southwell, L Beletsky American journal of public health 105 (8), 1530-1537, 2015 | 115 | 2015 |
| Physician continuing education to reduce opioid misuse, abuse, and overdose: Many opportunities, few requirements CS Davis, D Carr Drug and alcohol dependence 163, 100-107, 2016 | 104 | 2016 |
| The Law and Policy of Opioids for Pain Management, Addiction Treatment, and Overdose Reversal CS Davis, DH Carr Ind. Health L. Rev. 14, 1, 2017 | 49 | 2017 |
| Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States CS Davis, DH Carr International Journal of Drug Policy 73, 42-48, 2019 | 48 | 2019 |
| Paraphernalia Laws, Criminalizing Possession and Distribution of Items Used to Consume Illicit Drugs, and Injection-Related Harm CS Davis, DH Carr, EA Samuels American journal of public health 109 (11), 1564-1567, 2019 | 37 | 2019 |
| Over the counter naloxone needed to save lives in the United States CS Davis, D Carr Preventive medicine 130, 105932, 2020 | 31 | 2020 |
| Equity First: Conceptualizing a Normative Framework to Assess the Role of Preemption in Public Health D Carr, S Adler, BD Winig, JK Montez The Milbank Quarterly 98 (1), 131-149, 2020 | 29 | 2020 |
| Examining national public health law to realize the global health security agenda BM Meier, K Tureski, E Bockh, D Carr, A Ayala, A Roberts, L Cloud, ... Medical law review 25 (2), 240-269, 2017 | 24 | 2017 |
| Collaborating for health: health in all policies and the law D Pepin, BD Winig, D Carr, PD Jacobson The Journal of Law, Medicine & Ethics 45 (1_suppl), 60-64, 2017 | 21 | 2017 |
| Simulating the impact of a cigarette minimum floor price law on adult smoking prevalence in California SD Golden, KS Kim, AY Kong, VQ Tao, D Carr, P Musburger Nicotine and Tobacco Research 22 (10), 1842-1850, 2020 | 18 | 2020 |
| Self-regulating profession? Administrative discipline of “pill mill” physicians in Florida CS Davis, DH Carr Substance abuse 38 (3), 265-268, 2017 | 15 | 2017 |
| Legal interventions to reduce overdose mortality: naloxone access and overdose good samaritan laws. The Network for Public Health Law. 2016 C Davis, S Chang, D Carr, H Hernandez-Delgado | 15 | 2017 |
| Reducing harm through litigation against opioid manufacturers? Lessons from the tobacco wars D Carr, CS Davis, L Rutkow Public Health Reports 133 (2), 207-213, 2018 | 14 | 2018 |
| Advancing Diabetes-Related Equity Through Diabetes Self-Management Education and Training: Existing Coverage Requirements and Considerations for Increased Participation D Carr, M Kappagoda, L Boseman, LK Cloud, B Croom Journal of Public Health Management and Practice 26, S37-S44, 2020 | 12 | 2020 |
| Preemption, Public Health, and Equity in the Time of COVID-19 K Haddow, D Carr, BD Winig, S Adler Public Health, and Equity in the Time of COVID-19 (July 31, 2020). Burris, S …, 2020 | 11 | 2020 |
| Legal authority for emergency medical services to increase access to buprenorphine treatment for opioid use disorder CS Davis, DH Carr, MJ Glenn, EA Samuels Annals of Emergency Medicine 78 (1), 102-108, 2021 | 6 | 2021 |
| Naloxone affordability measures needed. C Davis, D Carr Journal of the American Pharmacists Association: Japha 57 (6), 740-741, 2017 | 5 | 2017 |
| Repealing State Drug-Paraphernalia Laws-The Need for Federal Leadership CS Davis, DH Carr The New England journal of medicine 387 (15), 1344-1346, 2022 | 4 | 2022 |
